These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28062037)

  • 21. Mechanism of foreign DNA recognition by a CRISPR RNA-guided surveillance complex from Pseudomonas aeruginosa.
    Rollins MF; Schuman JT; Paulus K; Bukhari HS; Wiedenheft B
    Nucleic Acids Res; 2015 Feb; 43(4):2216-22. PubMed ID: 25662606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of Cas10 Govern Discrimination between Self and Non-self in Type III CRISPR-Cas Immunity.
    Wang L; Mo CY; Wasserman MR; Rostøl JT; Marraffini LA; Liu S
    Mol Cell; 2019 Jan; 73(2):278-290.e4. PubMed ID: 30503774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural snapshots of R-loop formation by a type I-C CRISPR Cascade.
    O'Brien RE; Bravo JPK; Ramos D; Hibshman GN; Wright JT; Taylor DW
    Mol Cell; 2023 Mar; 83(5):746-758.e5. PubMed ID: 36805026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5' modifications to CRISPR-Cas9 gRNA can change the dynamics and size of R-loops and inhibit DNA cleavage.
    Mullally G; van Aelst K; Naqvi MM; Diffin FM; Karvelis T; Gasiunas G; Siksnys V; Szczelkun MD
    Nucleic Acids Res; 2020 Jul; 48(12):6811-6823. PubMed ID: 32496535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure basis for RNA-guided DNA degradation by Cascade and Cas3.
    Xiao Y; Luo M; Dolan AE; Liao M; Ke A
    Science; 2018 Jul; 361(6397):. PubMed ID: 29880725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA targeting by subtype I-D CRISPR-Cas shows type I and type III features.
    Lin J; Fuglsang A; Kjeldsen AL; Sun K; Bhoobalan-Chitty Y; Peng X
    Nucleic Acids Res; 2020 Oct; 48(18):10470-10478. PubMed ID: 32960267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The structural biology of CRISPR-Cas systems.
    Jiang F; Doudna JA
    Curr Opin Struct Biol; 2015 Feb; 30():100-111. PubMed ID: 25723899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cas3-Derived Target DNA Degradation Fragments Fuel Primed CRISPR Adaptation.
    Künne T; Kieper SN; Bannenberg JW; Vogel AI; Miellet WR; Klein M; Depken M; Suarez-Diez M; Brouns SJ
    Mol Cell; 2016 Sep; 63(5):852-64. PubMed ID: 27546790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease.
    Anders C; Niewoehner O; Duerst A; Jinek M
    Nature; 2014 Sep; 513(7519):569-73. PubMed ID: 25079318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into target DNA recognition and cleavage by the CRISPR-Cas12c1 system.
    Zhang B; Lin J; Perčulija V; Li Y; Lu Q; Chen J; Ouyang S
    Nucleic Acids Res; 2022 Nov; 50(20):11820-11833. PubMed ID: 36321657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type III-A CRISPR-Cas Csm Complexes: Assembly, Periodic RNA Cleavage, DNase Activity Regulation, and Autoimmunity.
    Jia N; Mo CY; Wang C; Eng ET; Marraffini LA; Patel DJ
    Mol Cell; 2019 Jan; 73(2):264-277.e5. PubMed ID: 30503773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fidelity of prespacer capture and processing is governed by the PAM-mediated interactions of Cas1-2 adaptation complex in CRISPR-Cas type I-E system.
    Yoganand KN; Muralidharan M; Nimkar S; Anand B
    J Biol Chem; 2019 Dec; 294(52):20039-20053. PubMed ID: 31748409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering of Cas12a nuclease variants with enhanced genome-editing specificity.
    Chen P; Zhou J; Liu H; Zhou E; He B; Wu Y; Wang H; Sun Z; Paek C; Lei J; Chen Y; Zhang X; Yin L
    PLoS Biol; 2024 Mar; 22(3):e3002514. PubMed ID: 38483978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination.
    Singh J; Liu KG; Allen A; Jiang W; Qin PZ
    Nucleic Acids Res; 2023 Sep; 51(16):8730-8743. PubMed ID: 37522352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9.
    Palermo G; Ricci CG; Fernando A; Basak R; Jinek M; Rivalta I; Batista VS; McCammon JA
    J Am Chem Soc; 2017 Nov; 139(45):16028-16031. PubMed ID: 28764328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activated DNA unwinding and degradation.
    Huo Y; Nam KH; Ding F; Lee H; Wu L; Xiao Y; Farchione MD; Zhou S; Rajashankar K; Kurinov I; Zhang R; Ke A
    Nat Struct Mol Biol; 2014 Sep; 21(9):771-7. PubMed ID: 25132177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type V CRISPR-Cas Cpf1 endonuclease employs a unique mechanism for crRNA-mediated target DNA recognition.
    Gao P; Yang H; Rajashankar KR; Huang Z; Patel DJ
    Cell Res; 2016 Aug; 26(8):901-13. PubMed ID: 27444870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determining the Specificity of Cascade Binding, Interference, and Primed Adaptation
    Cooper LA; Stringer AM; Wade JT
    mBio; 2018 Apr; 9(2):. PubMed ID: 29666291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic interplay between target search and recognition for a Type I CRISPR-Cas system.
    Aldag P; Rutkauskas M; Madariaga-Marcos J; Songailiene I; Sinkunas T; Kemmerich F; Kauert D; Siksnys V; Seidel R
    Nat Commun; 2023 Jun; 14(1):3654. PubMed ID: 37339984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cutting it close: CRISPR-associated endoribonuclease structure and function.
    Hochstrasser ML; Doudna JA
    Trends Biochem Sci; 2015 Jan; 40(1):58-66. PubMed ID: 25468820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.